Phesgo

Medicinal product

(Invented) name

Phesgo

Active substance (s)

Pertuzumabas/Trastuzumabas

Strength

600 mg/600 mg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FY01, pertuzumab and trastuzumab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2020-12-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	10 ml
Pertuzumabas	600 mg
Trastuzumabas	600 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105596	91696	1091696	flakonas	10 ml N1		Receptinis	EU/1/20/1497/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-21	Registruotas